Advisory Services Network, LLC Bria Cell Therapeutics Corp. Transaction History

Advisory Services Network, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$3.79 - $5.96 $1,137 - $1,788	300 New	300 $1,000
Q1 2023 May 17, 2023	SELL	$4.59 - $7.99 $2,418 - $4,210	-527 Reduced 44.77%	650 $4,000
Q4 2022 Feb 13, 2023	BUY	$4.28 - $6.73 $5,037 - $7,921	1,177 New	1,177 $5,000
Q3 2021 Nov 05, 2021	SELL	$4.4 - $9.28 $19,800 - $41,760	-4,500 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$2.89 - $6.57 $13,005 - $29,565	4,500 New	4,500 $24,000

Ticker BCTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,518,000
Market Cap $14.9M
Description
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.